Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide

Takuhiro Sonoyama, Naohisa Tamura, Kazutoshi Miyashita, Kwijun Park, Naofumi Oyamada, Daisuke Taura, Megumi Inuzuka, Yasutomo Fukunaga, Masakatsu Sone, Kazuwa Nakao

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Anti-fibrotic and organ protective effects of brain natriuretic peptide (BNP) have been reported. In this study, effects of BNP on liver fibrosis were examined in the carbon tetrachloride (CCl4)-induced liver fibrosis model using BNP-transgenic (Tg) and wild-type (WT) mice. Twice-a-week intraperitoneal injections of CCl4 for 8 weeks resulted in massive liver fibrosis, augmented transforming growth factor (TGF)-β1 and type I procollagen α1 chain (Col1a1) mRNA expression, and the hepatic stellate cell (HSC) activation in WT mice, all of which were significantly suppressed in Tg mice. These observations indicate that BNP inhibits liver fibrosis by attenuating the activation of HSCs.

Original languageEnglish
Pages (from-to)2067-2070
Number of pages4
JournalFEBS Letters
Volume583
Issue number12
DOIs
Publication statusPublished - 2009 Jun 18
Externally publishedYes

Fingerprint

Brain Natriuretic Peptide
Liver Cirrhosis
Liver
Collagen Type I
Transgenic Mice
Chemical activation
Hepatic Stellate Cells
Carbon Tetrachloride
Transforming Growth Factors
Intraperitoneal Injections
Messenger RNA

Keywords

  • Brain natriuretic peptide
  • Carbon tetrachloride
  • Guanylyl cyclase-A
  • Hepatic stellate cell
  • Liver fibrosis

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Structural Biology

Cite this

Sonoyama, T., Tamura, N., Miyashita, K., Park, K., Oyamada, N., Taura, D., ... Nakao, K. (2009). Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. FEBS Letters, 583(12), 2067-2070. https://doi.org/10.1016/j.febslet.2009.05.025

Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. / Sonoyama, Takuhiro; Tamura, Naohisa; Miyashita, Kazutoshi; Park, Kwijun; Oyamada, Naofumi; Taura, Daisuke; Inuzuka, Megumi; Fukunaga, Yasutomo; Sone, Masakatsu; Nakao, Kazuwa.

In: FEBS Letters, Vol. 583, No. 12, 18.06.2009, p. 2067-2070.

Research output: Contribution to journalArticle

Sonoyama, T, Tamura, N, Miyashita, K, Park, K, Oyamada, N, Taura, D, Inuzuka, M, Fukunaga, Y, Sone, M & Nakao, K 2009, 'Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide', FEBS Letters, vol. 583, no. 12, pp. 2067-2070. https://doi.org/10.1016/j.febslet.2009.05.025
Sonoyama T, Tamura N, Miyashita K, Park K, Oyamada N, Taura D et al. Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. FEBS Letters. 2009 Jun 18;583(12):2067-2070. https://doi.org/10.1016/j.febslet.2009.05.025
Sonoyama, Takuhiro ; Tamura, Naohisa ; Miyashita, Kazutoshi ; Park, Kwijun ; Oyamada, Naofumi ; Taura, Daisuke ; Inuzuka, Megumi ; Fukunaga, Yasutomo ; Sone, Masakatsu ; Nakao, Kazuwa. / Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. In: FEBS Letters. 2009 ; Vol. 583, No. 12. pp. 2067-2070.
@article{745a8155ddbd4c78a0814812c5e8e5a1,
title = "Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide",
abstract = "Anti-fibrotic and organ protective effects of brain natriuretic peptide (BNP) have been reported. In this study, effects of BNP on liver fibrosis were examined in the carbon tetrachloride (CCl4)-induced liver fibrosis model using BNP-transgenic (Tg) and wild-type (WT) mice. Twice-a-week intraperitoneal injections of CCl4 for 8 weeks resulted in massive liver fibrosis, augmented transforming growth factor (TGF)-β1 and type I procollagen α1 chain (Col1a1) mRNA expression, and the hepatic stellate cell (HSC) activation in WT mice, all of which were significantly suppressed in Tg mice. These observations indicate that BNP inhibits liver fibrosis by attenuating the activation of HSCs.",
keywords = "Brain natriuretic peptide, Carbon tetrachloride, Guanylyl cyclase-A, Hepatic stellate cell, Liver fibrosis",
author = "Takuhiro Sonoyama and Naohisa Tamura and Kazutoshi Miyashita and Kwijun Park and Naofumi Oyamada and Daisuke Taura and Megumi Inuzuka and Yasutomo Fukunaga and Masakatsu Sone and Kazuwa Nakao",
year = "2009",
month = "6",
day = "18",
doi = "10.1016/j.febslet.2009.05.025",
language = "English",
volume = "583",
pages = "2067--2070",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide

AU - Sonoyama, Takuhiro

AU - Tamura, Naohisa

AU - Miyashita, Kazutoshi

AU - Park, Kwijun

AU - Oyamada, Naofumi

AU - Taura, Daisuke

AU - Inuzuka, Megumi

AU - Fukunaga, Yasutomo

AU - Sone, Masakatsu

AU - Nakao, Kazuwa

PY - 2009/6/18

Y1 - 2009/6/18

N2 - Anti-fibrotic and organ protective effects of brain natriuretic peptide (BNP) have been reported. In this study, effects of BNP on liver fibrosis were examined in the carbon tetrachloride (CCl4)-induced liver fibrosis model using BNP-transgenic (Tg) and wild-type (WT) mice. Twice-a-week intraperitoneal injections of CCl4 for 8 weeks resulted in massive liver fibrosis, augmented transforming growth factor (TGF)-β1 and type I procollagen α1 chain (Col1a1) mRNA expression, and the hepatic stellate cell (HSC) activation in WT mice, all of which were significantly suppressed in Tg mice. These observations indicate that BNP inhibits liver fibrosis by attenuating the activation of HSCs.

AB - Anti-fibrotic and organ protective effects of brain natriuretic peptide (BNP) have been reported. In this study, effects of BNP on liver fibrosis were examined in the carbon tetrachloride (CCl4)-induced liver fibrosis model using BNP-transgenic (Tg) and wild-type (WT) mice. Twice-a-week intraperitoneal injections of CCl4 for 8 weeks resulted in massive liver fibrosis, augmented transforming growth factor (TGF)-β1 and type I procollagen α1 chain (Col1a1) mRNA expression, and the hepatic stellate cell (HSC) activation in WT mice, all of which were significantly suppressed in Tg mice. These observations indicate that BNP inhibits liver fibrosis by attenuating the activation of HSCs.

KW - Brain natriuretic peptide

KW - Carbon tetrachloride

KW - Guanylyl cyclase-A

KW - Hepatic stellate cell

KW - Liver fibrosis

UR - http://www.scopus.com/inward/record.url?scp=67349204034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349204034&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2009.05.025

DO - 10.1016/j.febslet.2009.05.025

M3 - Article

C2 - 19463821

AN - SCOPUS:67349204034

VL - 583

SP - 2067

EP - 2070

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 12

ER -